好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Insights from the Coptimize Study: Characteristics of Relapsing Remitting Multiple Sclerosis (RRMS) Patients Switching to Glatiramer Acetate
MS and Related Diseases
(-)
193
Authors/Disclosures
Tjalf Ziemssen, MD, FAAN (University Clinic Dresden) Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS . Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Dresden Internation University. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from BMS. The institution of Dr. Ziemssen has received research support from Roche.
Adriana J. Carra, MD No disclosure on file
No disclosure on file
Nina De Klippel, MD No disclosure on file
No disclosure on file
No disclosure on file
Olivier Heinzlef, MD (Hospital De Poissy) Dr. Heinzlef has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Heinzlef has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Heinzlef has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Edimark.
Nadine Knowles Nadine Knowles has received personal compensation for serving as an employee of Lundbeck. Nadine Knowles has received personal compensation for serving as an employee of Longboard Pharmaceuticals, inc.
Clementine Karageorgiou, MD (Neurological Institute of Athens) The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for GENESIS PHARMA. The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for TEVA-SPECIFAR.
Krisztina Kovacs, MD No disclosure on file
Anne-Marie Landtblom, MD, PhD (Motala Hospital, Neurology Dept) No disclosure on file
Lubomir Lisy, MD (Faculty Hospital) No disclosure on file
Ovidiu A. Bajenaru, MD, PhD (University of Medicine & Pharmacy"Carol Davila",UNIVERSITY HOSPITAL) No disclosure on file
Ching Piao Tsai, MD (Taipei Vaterans General Hospital) No disclosure on file
Niall Tubridy, MD (St Vincent's University Hospital) Dr. Tubridy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis .
Galina Vorobeychik, MD, FRCPC, FAAN (Fraser Health MS Clinic) Dr. Vorobeychik has nothing to disclose.